For the Inventor, By the Inventor

Enter assignee name

Trezzano Rosa, Italy

Sofar S.p.a.

USPTO Granted Patents = 13

% Expired Patents = 15.4

CIPO Patents = 3

EPO Patents = 7

Trademarks = 14

Forward Citations = 34

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Andrea Biffi (5 out of 14 patents)

Carla Labruzzo (5 out of 6 patents)

Alexis Grande (3 out of 3 patents)

4. Fabrizio Ferrarini (3 out of 3 patents)

5. Sandra Parenti (3 out of 3 patents)

6. Ruggero Rossi (3 out of 6 patents)

7. Walter Fiore (3 out of 9 patents)

8. Silvia Salamina (2 out of 2 patents)

9. Simone Guglielmetti (1 out of 3 patents)

10. Antonio Mannello (1 out of 1 patent)

11. Silvia Balzaretti (1 out of 1 patent)

12. Simone Domenico Guglielmetti (1 patent)

13. Gianalfredo Franzoni (0 patent)

14. Luigi Melgrati (0 patent)

15. Alfredo Maria Damiani (0 patent)

13 patents: Sort by Forward Citations

1. 11690889 - Composition for use in the treatment of intestinal alterations (2023-07-04),

2. 11591416 - Exopolysaccharides and uses thereof (2023-02-28),

3. 11504331 - Process for mesalazine solid formulations (2022-11-22),

4. 11464814 - Topical composition for use in the treatment of inflammatory bowel disease (2022-10-11),

5. 11400124 - Use of probiotics for improving protein absorption (2022-08-02),

6. 10905700 - Chemoprevention of colorectal cancer (2021-02-02),

7. 10881703 - Composition for use in the treatment of intestinal alterations (2021-01-05),

8. 10555956 - Chemoprevention of colorectal cancer (2020-02-11),

9. 10028917 - Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them (2018-07-24),

10. 9193673 - Derivatives of mesalazine, process of their preparation and their use in the treatment of intestinal inflammatory diseases (2015-11-24),

11. 8916201 - Controlled-release granular compositions containing mesalazine and process for the manufacture thereof (2014-12-23),

12. 8501442 - Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis (2013-08-06),

13. 5275312 - One-way valve suitable for use in particular in a container supplying a (1994-01-04),

Sofar S.p.a. is a prominent player in the field of advanced materials and technologies, specializing in the development and manufacturing of innovative solutions for various industries. The company focuses on creating high-performance products that enhance efficiency and sustainability across sectors such as automotive, aerospace, and energy. With a commitment to research and development, Sofar S.p.a. leverages cutting-edge technology to address complex challenges and drive progress in material science and engineering.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#1 in Trezzano Rosa

#714 in Italy

#44,988 in the World

Trezzano Rosa, Italy

Sofar S.p.a.

Forward Citations = 34

11 inventors:

Andrea Biffi (5 out of 14 patents)

Carla Labruzzo (5 out of 6 patents)

Alexis Grande (3 out of 3 patents)

4. Fabrizio Ferrarini (3 out of 3 patents)

5. Sandra Parenti (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…